Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery

• Status: Terminated
• Trial end date: 2019-08-30
• Target enrollment: 0
• Participant gender: Female

Summary

This is a randomized controlled pilot study evaluating length of pain control with either liposomal bupivacaine or with bupivacaine plus decadron after PEC II injection in patients having bilateral mastectomies with immediate reconstruction.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Prisma Health-Upstate
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Scheduled for bilateral mastectomy

Exclusion Criteria:

• allergy to local anesthetics, prior breast surgery, asymmetric surgical plan